Indivumed GmbH was founded to promote the development of individualized cancer therapies. It offers pharmaceutical and biotech companies a comprehensive analytical service platform from routine pathology to complex drug profiling and target validation studies: A complete, all-in-one-hand service for biospecimen and, in particular, tissue research.
Indivumeds’ service platform includes:
- Access to a unique biobank of the highest quality standard;
- A special clinical infrastructure allowing bench-patient-bench research;
- A comprehensive analytical research platform;
- Partners with special expertise, e.g. full pathology service.
